www.neurouroprograms.com
Open in
urlscan Pro
45.60.87.197
Public Scan
Submitted URL: http://neurouroprograms.com/masterclassondemand
Effective URL: https://www.neurouroprograms.com/masterclassondemand/meeting/164014/
Submission: On February 15 via manual from IN — Scanned from DE
Effective URL: https://www.neurouroprograms.com/masterclassondemand/meeting/164014/
Submission: On February 15 via manual from IN — Scanned from DE
Form analysis
1 forms found in the DOMPOST /masterclassondemand/meeting/164014/
<form method="post" accept-charset="utf-8" id="rsvp-form" class="form" action="/masterclassondemand/meeting/164014/">
<div style="display:none;"><input type="hidden" name="_csrfToken" autocomplete="off" value="xTS4NIyZjwWMKu6W/jPfW3b7n9SSQgjDBhri/ZxKebAqBkFN6/JQD5G0Kbg7Dumt2rCu3W2/WhCcYw+e1LE3Mhxi/nPObbd3Qsmmt6B1OfsyI9XNq3sciR9lJXrdxWRs8tcZjl9ripzriJy/CN5sdA==">
</div>
<div class="row">
<div class="col-lg-2 col-md-12 col-sm-12 col-xs-12">
<input type="text" name="first_name" class="width-100 form-control custom-input margin-bottom-15" placeholder="First Name" id="firstName" value=""> <label id="firstName-error" class="error" for="firstName" style="display:none"></label>
</div>
<div class="col-lg-2 col-md-12 col-sm-12 col-xs-12">
<input type="text" name="last_name" class="width-100 form-control custom-input margin-bottom-15 error" placeholder="Last Name*" id="lastName" required="required" value=""> <label id="lastName-error" class="error" for="lastName"
style="display:none"></label>
</div>
<div class="col-lg-4 col-md-12 col-sm-12 col-xs-12">
<div class="row">
<div class="col-lg-6 col-md-12">
<input type="text" name="npi_number" class="width-100 form-control custom-input margin-bottom-15 error" placeholder="NPI #*" id="npiNumber" maxlength="10" required="required" value="">
</div>
<div class="col-lg-6 col-md-12">
<input type="text" name="state_license" class="width-100 form-control custom-input margin-bottom-15 error" placeholder="State License #*" id="stateLicense" required="required" value="">
</div>
<label id="npiNumber-error" class="error col-xs-12" for="npiNumber" style="display:none"></label>
</div>
</div>
<div class="col-lg-2 col-md-12 col-sm-12 col-xs-12 custom-width">
<div class="dropdown bootstrap-select custom-select-input bs3"><select name="state" class="selectpicker custom-select-input" title="State" id="state" data-live-search="true" data-live-search-placeholder="Search State"
data-live-search-style="startsWith" data-header="&nbsp;" tabindex="-98">
<option class="bs-title-option" value=""></option>
<option value="" title="" data-tokens="" selected="selected"></option>
<option value="AL" title="AL" data-tokens="AL">Alabama</option>
<option value="AK" title="AK" data-tokens="AK">Alaska</option>
<option value="AS" title="AS" data-tokens="AS">American Samoa</option>
<option value="AZ" title="AZ" data-tokens="AZ">Arizona</option>
<option value="AR" title="AR" data-tokens="AR">Arkansas</option>
<option value="CA" title="CA" data-tokens="CA">California</option>
<option value="CO" title="CO" data-tokens="CO">Colorado</option>
<option value="CT" title="CT" data-tokens="CT">Connecticut</option>
<option value="DE" title="DE" data-tokens="DE">Delaware</option>
<option value="DC" title="DC" data-tokens="DC">District of Columbia</option>
<option value="FL" title="FL" data-tokens="FL">Florida</option>
<option value="GA" title="GA" data-tokens="GA">Georgia</option>
<option value="GU" title="GU" data-tokens="GU">Guam</option>
<option value="HI" title="HI" data-tokens="HI">Hawaii</option>
<option value="ID" title="ID" data-tokens="ID">Idaho</option>
<option value="IL" title="IL" data-tokens="IL">Illinois</option>
<option value="IN" title="IN" data-tokens="IN">Indiana</option>
<option value="IA" title="IA" data-tokens="IA">Iowa</option>
<option value="KS" title="KS" data-tokens="KS">Kansas</option>
<option value="KY" title="KY" data-tokens="KY">Kentucky</option>
<option value="LA" title="LA" data-tokens="LA">Louisiana</option>
<option value="ME" title="ME" data-tokens="ME">Maine</option>
<option value="MD" title="MD" data-tokens="MD">Maryland</option>
<option value="MA" title="MA" data-tokens="MA">Massachusetts</option>
<option value="MI" title="MI" data-tokens="MI">Michigan</option>
<option value="MN" title="MN" data-tokens="MN">Minnesota</option>
<option value="MS" title="MS" data-tokens="MS">Mississippi</option>
<option value="MO" title="MO" data-tokens="MO">Missouri</option>
<option value="MT" title="MT" data-tokens="MT">Montana</option>
<option value="NE" title="NE" data-tokens="NE">Nebraska</option>
<option value="NV" title="NV" data-tokens="NV">Nevada</option>
<option value="NH" title="NH" data-tokens="NH">New Hampshire</option>
<option value="NJ" title="NJ" data-tokens="NJ">New Jersey</option>
<option value="NM" title="NM" data-tokens="NM">New Mexico</option>
<option value="NY" title="NY" data-tokens="NY">New York</option>
<option value="NC" title="NC" data-tokens="NC">North Carolina</option>
<option value="ND" title="ND" data-tokens="ND">North Dakota</option>
<option value="MP" title="MP" data-tokens="MP">Northern Mariana Islands</option>
<option value="OH" title="OH" data-tokens="OH">Ohio</option>
<option value="OK" title="OK" data-tokens="OK">Oklahoma</option>
<option value="OR" title="OR" data-tokens="OR">Oregon</option>
<option value="PA" title="PA" data-tokens="PA">Pennsylvania</option>
<option value="PR" title="PR" data-tokens="PR">Puerto Rico</option>
<option value="RI" title="RI" data-tokens="RI">Rhode Island</option>
<option value="SC" title="SC" data-tokens="SC">South Carolina</option>
<option value="SD" title="SD" data-tokens="SD">South Dakota</option>
<option value="TN" title="TN" data-tokens="TN">Tennessee</option>
<option value="TX" title="TX" data-tokens="TX">Texas</option>
<option value="AA" title="AA" data-tokens="AA">U.S. Armed Forces of Americas</option>
<option value="AE" title="AE" data-tokens="AE">U.S. Armed Forces of Europe</option>
<option value="AP" title="AP" data-tokens="AP">U.S. Armed Forces of Pacific</option>
<option value="VI" title="VI" data-tokens="VI">U.S. Virgin Islands</option>
<option value="UT" title="UT" data-tokens="UT">Utah</option>
<option value="VT" title="VT" data-tokens="VT">Vermont</option>
<option value="VA" title="VA" data-tokens="VA">Virginia</option>
<option value="WA" title="WA" data-tokens="WA">Washington</option>
<option value="WV" title="WV" data-tokens="WV">West Virginia</option>
<option value="WI" title="WI" data-tokens="WI">Wisconsin</option>
<option value="WY" title="WY" data-tokens="WY">Wyoming</option>
</select><button type="button" class="btn dropdown-toggle bs-placeholder btn-default" data-toggle="dropdown" role="combobox" aria-owns="bs-select-1" aria-haspopup="listbox" aria-expanded="false" data-id="state" title="State">
<div class="filter-option">
<div class="filter-option-inner">
<div class="filter-option-inner-inner">State</div>
</div>
</div><span class="bs-caret"><span class="caret"></span></span>
</button>
<div class="dropdown-menu open" style="padding-top: 0px; max-height: 883.109px; overflow: hidden; min-height: 171px; min-width: 235px;">
<div class="popover-title"><button type="button" class="close" aria-hidden="true">Done</button> </div>
<div class="bs-searchbox"><input type="text" class="form-control" autocomplete="off" placeholder="Search State" role="combobox" aria-label="Search" aria-controls="bs-select-1" aria-autocomplete="list" aria-activedescendant="bs-select-1-0">
</div>
<div class="inner open" role="listbox" id="bs-select-1" tabindex="-1" style="max-height: 792.109px; overflow-y: auto; min-height: 80px;">
<ul class="dropdown-menu inner " role="presentation" style="margin-top: 0px; margin-bottom: 0px;">
<li class="selected active"><a role="option" id="bs-select-1-0" tabindex="0" aria-setsize="60" aria-posinset="1" class="active selected" aria-selected="true"><span class="text"></span></a></li>
<li><a role="option" id="bs-select-1-1" tabindex="0"><span class="text">Alabama</span></a></li>
<li><a role="option" id="bs-select-1-2" tabindex="0"><span class="text">Alaska</span></a></li>
<li><a role="option" id="bs-select-1-3" tabindex="0"><span class="text">American Samoa</span></a></li>
<li><a role="option" id="bs-select-1-4" tabindex="0"><span class="text">Arizona</span></a></li>
<li><a role="option" id="bs-select-1-5" tabindex="0"><span class="text">Arkansas</span></a></li>
<li><a role="option" id="bs-select-1-6" tabindex="0"><span class="text">California</span></a></li>
<li><a role="option" id="bs-select-1-7" tabindex="0"><span class="text">Colorado</span></a></li>
<li><a role="option" id="bs-select-1-8" tabindex="0"><span class="text">Connecticut</span></a></li>
<li><a role="option" id="bs-select-1-9" tabindex="0"><span class="text">Delaware</span></a></li>
<li><a role="option" id="bs-select-1-10" tabindex="0"><span class="text">District of Columbia</span></a></li>
<li><a role="option" id="bs-select-1-11" tabindex="0"><span class="text">Florida</span></a></li>
<li><a role="option" id="bs-select-1-12" tabindex="0"><span class="text">Georgia</span></a></li>
<li><a role="option" id="bs-select-1-13" tabindex="0"><span class="text">Guam</span></a></li>
<li><a role="option" id="bs-select-1-14" tabindex="0"><span class="text">Hawaii</span></a></li>
<li><a role="option" id="bs-select-1-15" tabindex="0"><span class="text">Idaho</span></a></li>
<li><a role="option" id="bs-select-1-16" tabindex="0"><span class="text">Illinois</span></a></li>
<li><a role="option" id="bs-select-1-17" tabindex="0"><span class="text">Indiana</span></a></li>
<li><a role="option" id="bs-select-1-18" tabindex="0"><span class="text">Iowa</span></a></li>
<li><a role="option" id="bs-select-1-19" tabindex="0"><span class="text">Kansas</span></a></li>
<li><a role="option" id="bs-select-1-20" tabindex="0"><span class="text">Kentucky</span></a></li>
<li><a role="option" id="bs-select-1-21" tabindex="0"><span class="text">Louisiana</span></a></li>
<li><a role="option" id="bs-select-1-22" tabindex="0"><span class="text">Maine</span></a></li>
<li><a role="option" id="bs-select-1-23" tabindex="0"><span class="text">Maryland</span></a></li>
<li><a role="option" id="bs-select-1-24" tabindex="0"><span class="text">Massachusetts</span></a></li>
<li><a role="option" id="bs-select-1-25" tabindex="0"><span class="text">Michigan</span></a></li>
<li><a role="option" id="bs-select-1-26" tabindex="0"><span class="text">Minnesota</span></a></li>
<li><a role="option" id="bs-select-1-27" tabindex="0"><span class="text">Mississippi</span></a></li>
<li><a role="option" id="bs-select-1-28" tabindex="0"><span class="text">Missouri</span></a></li>
<li><a role="option" id="bs-select-1-29" tabindex="0"><span class="text">Montana</span></a></li>
<li><a role="option" id="bs-select-1-30" tabindex="0"><span class="text">Nebraska</span></a></li>
<li><a role="option" id="bs-select-1-31" tabindex="0"><span class="text">Nevada</span></a></li>
<li><a role="option" id="bs-select-1-32" tabindex="0"><span class="text">New Hampshire</span></a></li>
<li><a role="option" id="bs-select-1-33" tabindex="0"><span class="text">New Jersey</span></a></li>
<li><a role="option" id="bs-select-1-34" tabindex="0"><span class="text">New Mexico</span></a></li>
<li><a role="option" id="bs-select-1-35" tabindex="0"><span class="text">New York</span></a></li>
<li><a role="option" id="bs-select-1-36" tabindex="0"><span class="text">North Carolina</span></a></li>
<li><a role="option" id="bs-select-1-37" tabindex="0"><span class="text">North Dakota</span></a></li>
<li><a role="option" id="bs-select-1-38" tabindex="0"><span class="text">Northern Mariana Islands</span></a></li>
<li><a role="option" id="bs-select-1-39" tabindex="0"><span class="text">Ohio</span></a></li>
<li><a role="option" id="bs-select-1-40" tabindex="0"><span class="text">Oklahoma</span></a></li>
<li><a role="option" id="bs-select-1-41" tabindex="0"><span class="text">Oregon</span></a></li>
<li><a role="option" id="bs-select-1-42" tabindex="0"><span class="text">Pennsylvania</span></a></li>
<li><a role="option" id="bs-select-1-43" tabindex="0"><span class="text">Puerto Rico</span></a></li>
<li><a role="option" id="bs-select-1-44" tabindex="0"><span class="text">Rhode Island</span></a></li>
<li><a role="option" id="bs-select-1-45" tabindex="0"><span class="text">South Carolina</span></a></li>
<li><a role="option" id="bs-select-1-46" tabindex="0"><span class="text">South Dakota</span></a></li>
<li><a role="option" id="bs-select-1-47" tabindex="0"><span class="text">Tennessee</span></a></li>
<li><a role="option" id="bs-select-1-48" tabindex="0"><span class="text">Texas</span></a></li>
<li><a role="option" id="bs-select-1-49" tabindex="0"><span class="text">U.S. Armed Forces of Americas</span></a></li>
<li><a role="option" id="bs-select-1-50" tabindex="0"><span class="text">U.S. Armed Forces of Europe</span></a></li>
<li><a role="option" id="bs-select-1-51" tabindex="0"><span class="text">U.S. Armed Forces of Pacific</span></a></li>
<li><a role="option" id="bs-select-1-52" tabindex="0"><span class="text">U.S. Virgin Islands</span></a></li>
<li><a role="option" id="bs-select-1-53" tabindex="0"><span class="text">Utah</span></a></li>
<li><a role="option" id="bs-select-1-54" tabindex="0"><span class="text">Vermont</span></a></li>
<li><a role="option" id="bs-select-1-55" tabindex="0"><span class="text">Virginia</span></a></li>
<li><a role="option" id="bs-select-1-56" tabindex="0"><span class="text">Washington</span></a></li>
<li><a role="option" id="bs-select-1-57" tabindex="0"><span class="text">West Virginia</span></a></li>
<li><a role="option" id="bs-select-1-58" tabindex="0"><span class="text">Wisconsin</span></a></li>
<li><a role="option" id="bs-select-1-59" tabindex="0"><span class="text">Wyoming</span></a></li>
</ul>
</div>
</div>
</div> <label id="state-error" class="error" for="state" style="display:none"></label>
</div>
<input type="hidden" name="pid" value="164014">
<div class="col-lg-2 col-md-12 col-sm-12 col-xs-12">
<button class="btn btn-lg btn-success width-100 disabled" id="search-button" type="button">
<span id="search-text"> Search </span>
<div id="loader" style="display:none;">
<img src="/img/loader.gif" alt="CakePHP" height="23px" width="25px">
</div>
</button>
</div>
<p class="error-asterisk float-right mt-10"> * These fields are required. </p>
<div class="col-lg-12 col-sm-12 col-xs-12">
<p> Note: You may enter NPI or License #. </p>
<p id="npi_register_link"> Don't have an NPI or License #? <a href="/masterclassondemand/meeting/164014/attendee/new">
Click here
</a> to register. </p>
</div>
</div>
</form>
Text Content
Full Prescribing Information, including Boxed Warning Medication Guide Program ID: MF164014 EVENT DETAILS * * TOPIC * Masterclass-On-Demand Series PROGRAM COORDINATOR Catie Suliga (732) 889-2600 CSULIGA@MEDFORCE.NET Please be advised that we will use your personally identifiable information to contact you about your participation at this program. This information will be shared only with AbbVie and Medforce in support of this program. If you are not an HCP, click here to register. AlabamaAlaskaAmerican SamoaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaGuamHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaNorthern Mariana IslandsOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasU.S. Armed Forces of AmericasU.S. Armed Forces of EuropeU.S. Armed Forces of PacificU.S. Virgin IslandsUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming State Done * * Alabama * Alaska * American Samoa * Arizona * Arkansas * California * Colorado * Connecticut * Delaware * District of Columbia * Florida * Georgia * Guam * Hawaii * Idaho * Illinois * Indiana * Iowa * Kansas * Kentucky * Louisiana * Maine * Maryland * Massachusetts * Michigan * Minnesota * Mississippi * Missouri * Montana * Nebraska * Nevada * New Hampshire * New Jersey * New Mexico * New York * North Carolina * North Dakota * Northern Mariana Islands * Ohio * Oklahoma * Oregon * Pennsylvania * Puerto Rico * Rhode Island * South Carolina * South Dakota * Tennessee * Texas * U.S. Armed Forces of Americas * U.S. Armed Forces of Europe * U.S. Armed Forces of Pacific * U.S. Virgin Islands * Utah * Vermont * Virginia * Washington * West Virginia * Wisconsin * Wyoming Search * These fields are required. Note: You may enter NPI or License #. Don't have an NPI or License #? Click here to register. SEARCH RESULTS Not You? Add New Name Credential Address NO RESULTS TRY A NEW SEARCH, OR ADD NEW YOU'RE INVITED TO ATTEND AN ABBVIE PROGRAM! Topic * Masterclass-On-Demand Series PROGRAM COORDINATOR Catie Suliga (732) 889-2600 csuliga@medforce.net INDICATION AND IMPORTANT SAFETY INFORMATION Expand CHRONIC MIGRAINE BOTOX® is indicated for the prophylaxis of headaches in adult patients with Chronic Migraine (≥ 15 days per month with headache lasting 4 hours a day or longer). LIMITATIONS OF USE Safety and effectiveness have not been established for the prophylaxis of episodic migraine (14 headache days or fewer per month) in 7 placebo-controlled studies. IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of BOTOX® and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat Cervical Dystonia and spasticity and at lower doses. CONTRAINDICATIONS BOTOX® is contraindicated in the presence of infection at the proposed injection site(s) and in patients who are hypersensitive to any botulinum toxin product or to any of the components in the formulation. WARNINGS AND PRECAUTIONS SPREAD OF TOXIN EFFECT See Boxed Warning. No definitive serious adverse event reports of distant spread of toxin effect associated with BOTOX® for Chronic Migraine at the labeled doses have been reported. Lack of Interchangeability Between Botulinum Toxin Products The potency Units of BOTOX® are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, Units of biological activity of BOTOX® cannot be compared to nor converted into Units of any other botulinum toxin products assessed with any other specific assay method. SERIOUS ADVERSE REACTIONS WITH UNAPPROVED USE Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established. HYPERSENSITIVITY REACTIONS Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such a reaction occurs, further injection of BOTOX® should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent, and consequently the causal agent cannot be reliably determined. INCREASED RISK OF CLINICALLY SIGNIFICANT EFFECTS WITH PRE-EXISTING NEUROMUSCULAR DISORDERS Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis (ALS), or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with known or unrecognized neuromuscular disorders or neuromuscular junction disorders may be at increased risk of clinically significant effects, including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from therapeutic doses of BOTOX® (see Warnings and Precautions). DYSPHAGIA AND BREATHING DIFFICULTIES Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning). HUMAN ALBUMIN AND TRANSMISSION OF VIRAL DISEASES This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD, or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products. ADVERSE REACTIONS Adverse reactions to BOTOX® for injection are discussed in greater detail in the following sections: Boxed Warning, Contraindications, and Warnings and Precautions. CHRONIC MIGRAINE The most frequently reported adverse reactions following injection of BOTOX® for Chronic Migraine include neck pain (9%), headache (5%), eyelid ptosis (4%), migraine (4%), muscular weakness (4%), musculoskeletal stiffness (4%), bronchitis (3%), injection-site pain (3%), musculoskeletal pain (3%), myalgia (3%), facial paresis (2%), hypertension (2%), and muscle spasms (2%). Severe worsening of migraine requiring hospitalization occurred in approximately 1 of BOTOX treated patients in study 1 and study 2, usually within the first week after treatment, compared to 0.3% of placebo-treated patients. POSTMARKETING EXPERIENCE Adverse reactions that have been identified during postapproval use of BOTOX® are discussed in greater detail in Postmarketing Experience (Section 6.3 of the Prescribing Information). There have been spontaneous reports of death, sometimes associated with dysphagia, pneumonia, and/or other significant debility or anaphylaxis, after treatment with botulinum toxin. There have also been reports of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including cardiovascular disease. The exact relationship of these events to the botulinum toxin injection has not been established. DRUG INTERACTIONS Co-administration of BOTOX® and other agents interfering with neuromuscular transmission (eg, aminoglycosides, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® may potentiate systemic anticholinergic effects. The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin. Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX®. Please see full Prescribing Information, including Boxed Warning and Medication Guide . Allergan adheres to all applicable federal and state laws and regulations, including disclosure requirements. Attendance at speaker programs is limited to active healthcare professionals. Accordingly, we appreciate your support in not bringing a spouse and/or guest to this promotional program. Additional attendance restrictions may apply based on specific state or federal requirements and where otherwise prohibited by law. It is Abbvie policy to only include healthcare professionals who are involved in patient care consistent with our product indication(s). For any technical difficulties contact: Medforce at (888) 358-5572 or support@allerganspeakerprograms.com Privacy Policy | Legal Notice | Cookies Settings © 2023 AbbVie. All rights reserved. BOTOX® and its design are registered trademarks of Allergan, Inc., an AbbVie company. All trademarks are the property of their respective owners. US-BCM-220071 04/22 This site uses online tracking technologies such as cookies to personalize content, save your preferences, provide social media features, enable personalized advertising and track the site’s performance as described in our Privacy Notice. Please click on Cookies Settings below to manage your preferences. Cookies Settings PRIVACY PREFERENCE CENTER When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. You can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. More information MANAGE CONSENT PREFERENCES REQUIRED COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They may be set by us or by third party providers whose services we have added to our pages. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. FUNCTIONAL COOKIES Always Active These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They may be set by us or by third party providers whose services we have added to our pages. They help us to know which pages are the most and least popular and see how visitors move around the site. Back Button PERFORMANCE COOKIES Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Confirm My Choices